Our Business
Global Reporting Frameworks
Pfizer continues to evaluate our approach to non-financial reporting, including adherence to several existing, globally recognized external frameworks.
These include the Global Reporting Initiative (GRI), the Sustainability Accounting Standards Board (SASB) and the International Integrated Reporting Council (IIRC). We have relied on elements of each framework in developing this year's Annual Review while adhering to none in its entirety. We have included a GRI Reference Table in this Annual Review as a reference tool to help readers more readily locate relevant information across Pfizer's web-based resources.
Download GRI Reference Table
We also take into account elements of other Environment, Social and Governance (ESG) indices and sustainability indicators, in particular the Access to Medicines Index and the United Nations (UN) Sustainable Development Goals (SDGs).
GRI Reference Table
GRI Indicator | Description | Reference | Alignment with the UN SDGs1 |
---|---|---|---|
Strategy and Analysis | |||
G4-1 | CEO/Chair Statement | CEO Letter — To Our Stakeholders | |
Organizational Profile | |||
G4-3 | Company name | Pfizer Inc. | |
G4-4 | Company brand, products and services | CEO Letter | |
G4-5 | Location of headquarters | New York, New York (U.S.) | |
G4-6 | Main countries of operation | Global Commercial Businesses | |
G4-8 | Markets served (e.g. sectors, customers) | Our Business | |
G4-9 | Scale of company (e.g. employees, sales) | CEO Letter | |
G4-10 | Employee profile | Pfizer Careers | Goal 8 |
G4-12 | Description of company supply chain | Our Business | |
G4-14 | Precautionary approach / principle | Pfizer manages and reports on our risks and impacts in consideration of the precautionary principle. | |
Identified Material Aspects and Boundaries | |||
G4-17 | Entities included in financial statements | About this Review | |
G4-18 | Process for defining report content | About this Review | |
G4-19 | Material issues / aspects identified | About this Review | |
G4-23 | Significant changes in scope / boundaries | Pfizer footprint and capabilities grew with the acquisition of AstraZeneca's anti-infectives portfolio, Bamboo Therapeutics, BIND Therapeutics, and Medivation, Inc. which are included in the 2016 Annual Review | |
Stakeholder Engagement | |||
G4-24 | Stakeholders engaged | CEO Letter | |
G4-26 | Approach to stakeholder engagement | Partnerships | |
Report Profile | |||
G4-28 | Reporting period | About this Review | |
G4-29 | Date of previous report | See Previous Annual Review | |
G4-30 | Reporting cycle | About this Review | |
G4-31 | Reporting contact point | Chris Gray, Senior Director, Corporate Responsibility | |
G4-32 | In accordance option chosen | GRI Reference Table | |
Governance | |||
G4-34 | Governance structure | Governance and Ethics | |
G4-37 | Governance and stakeholder engagement | Corporate Governance FAQs | |
G4-38 | Composition of the Board | Board of Directors | |
G4-39 | Chair of the Board | Board of Directors | |
G4-40 | Nomination of Board Members | The Pfizer Board: Board Policies | |
G4-41 | Conflict of interest and the Board | The Pfizer Board: Board Policies | |
Ethics and Integrity | |||
G4-56 | Values, principles and codes | Pfizer Compliance | |
Economic | |||
DMA | Disclosures on Management Approach | SDGs | |
G4-EC1 | Direct economic value | Transforming Delivery of High Quality Products | |
G4-EC7 | Infrastructure investments and services | Bringing Resources to Bear to Improve Global Health | |
G4-EC9 | Local supplier spending | Transforming Delivery of High Quality Products | |
Environmental | |||
DMA | Disclosures on Management Approach | Environment, Health and Safety | |
G4-EN8 | Total water withdrawal by source | Environment, Health and Safety | |
G4-EN23 | Total waste | Environment, Health and Safety | |
G4-EN27 | Mitigation of product impacts | Environment, Health and Safety | |
G4-EN33 | Supply chain environmental impacts | Environment, Health and Safety | |
Social: Labor practices and decent work | |||
DMA | Disclosures on Management Approach | Culture | |
G4-LA6 | Injuries and work related fatalities | Culture | |
G4-LA9 | Employee training | Culture | |
G4-LA10 | Employee skills and learning | Culture | |
Social: Human rights | |||
DMA | Disclosures on Management Approach | Governance and Ethics | |
G4-HR2 | Human rights training | Human Rights Statement | |
G4-HR3 | Discrimination | Culture | |
Social: Society | |||
DMA | Disclosures on Management Approach | Governance and Ethics | |
G4-SO1 | Local community engagement | Public Health Impact | |
G4-SO2 | Impacts on local communities | Public Health Impact | |
G4-SO3 | Anti-corruption risk | Practical Ethical Sales and Marketing | |
G4-SO6 | Political contributions | Corporate and Shareholder Information | |
Social: Product responsibility | |||
DMA | Disclosures on Management Approach | ||
G4-PR1 | Health and safety impacts of products | Manufacturing and Supply Chain | |
G4-PR5 | Customer satisfaction | Access to Medicines | |
G4-PR8 | Customer privacy breaches | Clinical Trials |
- Based on a more detailed analysis available on the SDG Compass website.
No Poverty
Zero Hunger
Good Health and Well-Being
We promote holistic solutions to meet the health needs of the underserved while investing in the well-being of the global community.
Quality Education
Gender Equality
We seek to empower and mobilize women around the world through partnerships aimed at ensuring access to quality health care, including newborn immunizations and family planning services.
Clean Water and Sanitation
Through public-private partnerships like the International Trachoma Initiative, as well as efforts to responsibly manage our water consumption and disposal, we aim to advance public health by improving water supply, sanitation and hygiene.
Affordable and Clean Energy
Decent Work and Economic Growth
Industry, Innovation and Infrastructure
We catalyze scientific innovation through cutting-edge research initiatives and unique, results-driven partnerships in order to deliver novel medicines, vaccines and know-how to individuals around the world.
Reduced Inequalities
Sustainable Cities and Communities
We promote healthy behavior for people of all ages in urban environments through programs to reduce pollution, promote age-friendly policies and improve health services for those most in need.
Responsible Consumption and Production
Throughout the lifecycle of our products, we are working toward reducing our carbon footprint and increasing energy efficiency, decreasing dependence on limited resources and reducing waste.
Climate Action
Life Below Water
Life On Land
Peace, Justice and Strong Institutions
Partnerships for the Goals
Through innovative partnerships, including collaborations with non-governmental organizations (NGOs), governments, foundations, social entrepreneurs and colleagues, we seek to fuel creative approaches that accelerate progress and improve health care.